BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24051374)

  • 21. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein.
    He L; Sabet A; Djedjos S; Miller R; Sun X; Hussain MA; Radovick S; Wondisford FE
    Cell; 2009 May; 137(4):635-46. PubMed ID: 19450513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone phosphorylation integrates the hepatic glucagon-PKA-CREB gluconeogenesis program in response to fasting.
    Zhao Y; Li S; Chen Y; Wang Y; Wei Y; Zhou T; Zhang Y; Yang Y; Chen L; Liu Y; Hu C; Zhou B; Ding Q
    Mol Cell; 2023 Apr; 83(7):1093-1108.e8. PubMed ID: 36863348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRTC2 Is a Coactivator of GR and Couples GR and CREB in the Regulation of Hepatic Gluconeogenesis.
    Hill MJ; Suzuki S; Segars JH; Kino T
    Mol Endocrinol; 2016 Jan; 30(1):104-17. PubMed ID: 26652733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arginine methylation of CRTC2 is critical in the transcriptional control of hepatic glucose metabolism.
    Han HS; Jung CY; Yoon YS; Choi S; Choi D; Kang G; Park KG; Kim ST; Koo SH
    Sci Signal; 2014 Feb; 7(314):ra19. PubMed ID: 24570487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PPP1R3C mediates metformin-inhibited hepatic gluconeogenesis.
    Ji X; Wang S; Tang H; Zhang Y; Zhou F; Zhang L; Zhu Q; Zhu K; Liu Q; Liu Y; Wang X; Zhou L
    Metabolism; 2019 Sep; 98():62-75. PubMed ID: 31181215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional co-activator p300 maintains basal hepatic gluconeogenesis.
    He L; Naik K; Meng S; Cao J; Sidhaye AR; Ma A; Radovick S; Wondisford FE
    J Biol Chem; 2012 Sep; 287(38):32069-77. PubMed ID: 22815486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis.
    Zhang EE; Liu Y; Dentin R; Pongsawakul PY; Liu AC; Hirota T; Nusinow DA; Sun X; Landais S; Kodama Y; Brenner DA; Montminy M; Kay SA
    Nat Med; 2010 Oct; 16(10):1152-6. PubMed ID: 20852621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling.
    Canettieri G; Koo SH; Berdeaux R; Heredia J; Hedrick S; Zhang X; Montminy M
    Cell Metab; 2005 Nov; 2(5):331-8. PubMed ID: 16271533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sam68 promotes hepatic gluconeogenesis via CRTC2.
    Qiao A; Zhou J; Xu S; Ma W; Boriboun C; Kim T; Yan B; Deng J; Yang L; Zhang E; Song Y; Ma YC; Richard S; Zhang C; Qiu H; Habegger KM; Zhang J; Qin G
    Nat Commun; 2021 Jun; 12(1):3340. PubMed ID: 34099657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucagon up-regulates hepatic mitochondrial pyruvate carrier 1 through cAMP-responsive element-binding protein; inhibition of hepatic gluconeogenesis by ginsenoside Rb1.
    Lou MD; Li J; Cheng Y; Xiao N; Ma G; Li P; Liu B; Liu Q; Qi LW
    Br J Pharmacol; 2019 Aug; 176(16):2962-2976. PubMed ID: 31166615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.
    Lee JM; Seo WY; Song KH; Chanda D; Kim YD; Kim DK; Lee MW; Ryu D; Kim YH; Noh JR; Lee CH; Chiang JY; Koo SH; Choi HS
    J Biol Chem; 2010 Oct; 285(42):32182-91. PubMed ID: 20688914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Methionine Transamination Pathway Controls Hepatic Glucose Metabolism through Regulation of the GCN5 Acetyltransferase and the PGC-1α Transcriptional Coactivator.
    Tavares CD; Sharabi K; Dominy JE; Lee Y; Isasa M; Orozco JM; Jedrychowski MP; Kamenecka TM; Griffin PR; Gygi SP; Puigserver P
    J Biol Chem; 2016 May; 291(20):10635-45. PubMed ID: 27022023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulated TGF-β1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling.
    Xiao Y; Wang Y; Ryu J; Liu W; Zou H; Zhang R; Yan Y; Dai Z; Zhang D; Sun LZ; Liu F; Zhou Z; Dong LQ
    Diabetologia; 2023 Jun; 66(6):1142-1155. PubMed ID: 36917279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes.
    Sharabi K; Lin H; Tavares CDJ; Dominy JE; Camporez JP; Perry RJ; Schilling R; Rines AK; Lee J; Hickey M; Bennion M; Palmer M; Nag PP; Bittker JA; Perez J; Jedrychowski MP; Ozcan U; Gygi SP; Kamenecka TM; Shulman GI; Schreiber SL; Griffin PR; Puigserver P
    Cell; 2017 Mar; 169(1):148-160.e15. PubMed ID: 28340340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
    Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
    Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid stimulating hormone increases hepatic gluconeogenesis via CRTC2.
    Li Y; Wang L; Zhou L; Song Y; Ma S; Yu C; Zhao J; Xu C; Gao L
    Mol Cell Endocrinol; 2017 May; 446():70-80. PubMed ID: 28212844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proline hydroxylation of CREB-regulated transcriptional coactivator 2 controls hepatic glucose metabolism.
    Xue Y; Cui A; Wei S; Ma F; Liu Z; Fang X; Huo S; Sun X; Li W; Hu Z; Liu Y; Cai G; Su W; Zhao J; Yan X; Gao C; Wen J; Zhang H; Li H; Liu Y; Lin X; Xu Y; Fu W; Fang J; Li Y
    Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2219419120. PubMed ID: 37252972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
    Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS
    Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis.
    Yoon YS; Ryu D; Lee MW; Hong S; Koo SH
    Exp Mol Med; 2009 Aug; 41(8):577-83. PubMed ID: 19381067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The GCN5-CITED2-PKA signalling module controls hepatic glucose metabolism through a cAMP-induced substrate switch.
    Sakai M; Tujimura-Hayakawa T; Yagi T; Yano H; Mitsushima M; Unoki-Kubota H; Kaburagi Y; Inoue H; Kido Y; Kasuga M; Matsumoto M
    Nat Commun; 2016 Nov; 7():13147. PubMed ID: 27874008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.